Back to VP VANGUARD PORTFOLIO MANAGEMENT LLC
TRVI2 quarters
Position history for VPVANGUARD PORTFOLIO MANAGEMENT LLC's holdings in TREVI THERAPEUTICS INC
Yes. Vanguard Portfolio Management holds 1,176,872 shares of TRVI (Trevi Therapeutics), worth $21.9M, as of its Q2 2026 13F filing. It increased the position by 208,284 shares (+21.5%) from Q1 2026. Vanguard Portfolio Management has held TRVI in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$21.9M
Current Shares
1.2M
Total Value Change
+$10.4M
Total Shares Change
+208,284
Quarter-by-Quarter History
Other major holders of TRVI: FMR LLC, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP